
Amicus Therapeutics Investor Relations Material
Latest events

Q4 2024
Amicus Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Amicus Therapeutics Inc
Access all reports
Amicus Therapeutics Inc. is a biotechnology company focused on developing and commercializing treatments for rare and orphan diseases. The company specializes in therapies for lysosomal storage disorders and other genetic conditions, leveraging proprietary technologies in protein engineering and gene therapy. Amicus Therapeutics Inc. is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Amicus Therapeutics Inc


Q4 2024
Amicus Therapeutics Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Amicus Therapeutics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
FOLD
Country
🇺🇸 United States